Patent Expiry

Patent/Exclusivity Expiry: OGSIVEO

May 19, 2043

Company: Allogene Therapeutics, Inc. (ALLO)
Drug: OGSIVEO

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start Free Full Calendar

Patent/Exclusivity Expiry: OGSIVEO — ALLO Patent Expiry | BioSniper